Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-14

Clinical Trial Update: Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports on the potential benefits of alpha-blocker monotherapy for lower urinary tract symptoms in men with benign prostatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha-blocker (monotherapy)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Benign Prostate Hyperplasia | Phase 4 | Status: UNKNOWN